OTCMKTS:HCYTD H-CYTE (HCYTD) News Today $2.02 -1.98 (-49.50%) (As of 07/11/2022) Add Compare Share Share Today's Range$2.02▼$2.7750-Day Range$2.02▼$2.0252-Week Range$2.02▼$77.00Volume400 shsAverage Volume103 shsMarket Capitalization$521,160.00P/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineH-E-B Grocery Companyforbes.com - June 14 at 4:23 AM10-K: H-CYTE, INC.marketwatch.com - May 12 at 3:12 PMHCYT H-CYTE, Inc.seekingalpha.com - March 24 at 10:19 AMH-CYTE Completes Acquisition of Jantibodyfinance.yahoo.com - September 8 at 8:15 AMH-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Daysapnews.com - July 23 at 2:03 PMH-CYTE Announces 1-for-1,000 Reverse Stock Splitfinance.yahoo.com - June 13 at 9:25 AMShould You Refrigerate Peanut Butter?yahoo.com - March 6 at 2:10 AMNetflix’s new superhero show might be the weirdest thing you ever watchyahoo.com - March 6 at 2:10 AMH-CYTE Announces Proceeds of $1.05 Million from Warrant Exercisefinance.yahoo.com - March 4 at 7:46 PMH-CYTE Inc (HCYT)nasdaq.com - February 7 at 10:18 PMH-CYTE signs letter of intent to acquire Catheter Precisionseekingalpha.com - January 11 at 9:47 AMH-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.finance.yahoo.com - January 11 at 9:47 AMH-CYTE Names Michael Yurkowsky Chief Executive Officerfinance.yahoo.com - December 6 at 10:05 AMItalian court seeks opinion on Berlusconi's health due to trial delaysau.finance.yahoo.com - September 9 at 9:48 PMH-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Healthfinance.yahoo.com - September 8 at 4:58 PMJefferson Lines takes proactive steps toward crisis management with TSA I-STEP trainingca.finance.yahoo.com - July 7 at 7:31 PMScanfil plc: Managers' transactions – Jokitaloin.finance.yahoo.com - July 7 at 7:31 PMH-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Healthfinance.yahoo.com - July 6 at 8:50 AMConstellium supplies advanced aluminium solutions for the electric Audi e-tron GTin.finance.yahoo.com - July 1 at 7:54 AMNetNumber Named as One of the “10 Most Disruptive Companies of 2021” by Exceleon Magazineau.finance.yahoo.com - July 1 at 7:54 AMH-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Healthfinance.yahoo.com - June 29 at 10:09 AMNew Providence CEO: 'We have a responsibility and accountability to the community'msn.com - October 4 at 2:13 PMRobert Greif named Chief Executive Officer of H-CYTEfeeds.benzinga.com - September 29 at 6:39 PMThree Canada Stocks who's Volume Surged on Bullish Signals: $VS $PPR $QROmarketwatch.com - September 27 at 11:46 AMH-CYTE Extends Rights Offering to 5:00 PM Eastern Time on Friday, September 11, 2020finance.yahoo.com - September 2 at 9:36 AMTSX rises on energy gains, U.S. services sector reboundwww.nasdaq.com - July 6 at 1:52 PMCANADA STOCKS-TSX rises on energy gains, U.S. services sector reboundwww.reuters.com - July 6 at 1:52 PMPrairie Provident Provides an Update on Lending Facilityfinance.yahoo.com - April 21 at 6:31 PMPrairie Provident Resources Announces Fourth Quarter and Year-End 2019 Financial and Operating Resultswww.globenewswire.com - March 26 at 11:14 PMPrairie Provident Resources Announces Updated Corporate Presentationwww.globenewswire.com - February 18 at 8:12 AMH-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directorsfinance.yahoo.com - January 28 at 8:39 AMH-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPDfinance.yahoo.com - January 28 at 8:39 AMH-CYTE Issues Letter to Shareholdersfinance.yahoo.com - January 28 at 8:39 AM Get H-CYTE News Delivered to You Automatically Sign up to receive the latest news and ratings for HCYTD and its competitors with MarketBeat's FREE daily newsletter. Email Address HCYTD Media Mentions By Week HCYTD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCYTD News Sentiment▼0.000.70▲Average Medical News Sentiment HCYTD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCYTD Articles This Week▼00▲HCYTD Articles Average Week Get H-CYTE News Delivered to You Automatically Sign up to receive the latest news and ratings for HCYTD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TOMDF News Today USAQ News Today LENSF News Today HDII News Today VRSEF News Today QTXB News Today OCLG News Today IONM News Today RSLS News Today AMBS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (OTCMKTS:HCYTD) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding H-CYTE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.